Christopher P Evans Selected Research

Therapeutics

10/2023	Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review.
7/2023	The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature.
1/2023	The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.
1/2023	Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.
1/2023	Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
10/2022	Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment.
7/2022	The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer.
1/2022	Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes.
1/2022	Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.
11/2021	Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher P Evans Research Topics

Disease

124	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 03/2004
85	Neoplasms (Cancer) 02/2024 - 10/2002
19	Neoplasm Metastasis (Metastasis) 07/2023 - 03/2004
12	Urinary Bladder Neoplasms (Bladder Cancer) 09/2023 - 10/2002
11	Renal Cell Carcinoma (Grawitz Tumor) 06/2023 - 05/2006
7	Carcinoma (Carcinomatosis) 01/2019 - 10/2002
4	Kidney Neoplasms (Kidney Cancer) 05/2011 - 10/2005
3	Disease Progression 11/2022 - 04/2009
3	Thrombosis (Thrombus) 01/2018 - 02/2015
3	Carcinogenesis 01/2018 - 12/2007
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2007 - 09/2002
2	Lung Neoplasms (Lung Cancer) 09/2023 - 04/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 03/2020
2	Melanoma (Melanoma, Malignant) 12/2020 - 12/2019
2	Non-Muscle Invasive Bladder Neoplasms 01/2018 - 10/2007
2	Fatigue 01/2017 - 07/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 10/2002
2	Hypertension (High Blood Pressure) 07/2014 - 04/2008
2	Urologic Neoplasms (Urological Cancer) 05/2011 - 02/2009
2	Transitional Cell Carcinoma 02/2010 - 05/2003
2	Testicular Neoplasms (Testicular Cancer) 01/2004 - 02/2003
2	Lower Urinary Tract Symptoms 08/2003 - 09/2002

Drug/Important Bio-Agent (IBA)

45	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 03/2004
41	AndrogensIBA 10/2023 - 03/2004
32	enzalutamideIBA 01/2023 - 08/2013
14	Hormones (Hormone)IBA 01/2023 - 01/2005
13	abirateroneIBA 10/2022 - 03/2015
10	Androgen Antagonists (Antiandrogens)IBA 01/2023 - 03/2009
9	Docetaxel (Taxotere)FDA Link 01/2022 - 09/2013
8	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 06/2004
7	Biomarkers (Surrogate Marker)IBA 09/2023 - 02/2009
6	AntigensIBA 07/2023 - 03/2009
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2013
6	Interleukin-6 (Interleukin 6)IBA 09/2015 - 03/2009
6	saracatinibIBA 06/2010 - 04/2008
5	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2023 - 11/2011
5	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2020
5	Small Interfering RNA (siRNA)IBA 10/2022 - 04/2008
5	cabazitaxel FDA Link 10/2021 - 06/2017
5	MicroRNAs (MicroRNA)IBA 07/2014 - 12/2007
5	src-Family KinasesIBA 06/2012 - 04/2008
4	LigandsIBA 01/2022 - 08/2013
4	apalutamideIBA 01/2021 - 03/2015
4	Niclosamide FDA Link 01/2021 - 06/2014
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2024 - 07/2019
3	olaparibIBA 02/2024 - 07/2019
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 11/2018
3	UbiquitinIBA 01/2023 - 11/2018
3	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2020
3	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 10/2021 - 10/2019
3	Leuprolide (Lupron)FDA LinkGeneric 10/2021 - 10/2019
3	taxaneIBA 10/2021 - 10/2018
3	Phosphotransferases (Kinase)IBA 12/2019 - 02/2007
3	Testosterone (Sustanon)FDA Link 10/2019 - 08/2009
3	bicalutamide (Casodex)FDA LinkGeneric 01/2017 - 03/2009
3	Tyrosine Kinase InhibitorsIBA 01/2010 - 03/2004
3	NeuropeptidesIBA 03/2009 - 01/2009
2	hydrogen sulfite (bisulfite)IBA 01/2023 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2023 - 07/2022
2	ChemokinesIBA 07/2022 - 03/2004
2	darolutamideIBA 01/2021 - 01/2020
2	Taxoids (Taxanes)IBA 01/2020 - 10/2018
2	SteroidsIBA 10/2019 - 04/2015
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2017 - 04/2015
2	TOR Serine-Threonine KinasesIBA 01/2016 - 05/2012
2	Chloroquine (Aralen)FDA LinkGeneric 09/2014 - 01/2010
2	Dasatinib (BMS 354825)FDA Link 12/2013 - 02/2007
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 03/2004
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2013 - 06/2012
2	AlkaloidsIBA 01/2012 - 03/2010
2	SurvivinIBA 01/2012 - 03/2010
2	sanguinarineIBA 01/2012 - 03/2010
2	andrographolideIBA 02/2011 - 08/2010
2	Tyrosine (L-Tyrosine)FDA Link 01/2010 - 02/2007
1	Dihydrotachysterol (AT 10)IBA 06/2023
1	B7-H1 AntigenIBA 01/2023
1	Calcibiotic Root Canal SealerIBA 01/2023
1	ChromatinIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	atezolizumabIBA 01/2023
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2023
1	Interferon-alpha (Interferon Alfa)IBA 01/2023

Therapy/Procedure

72	Castration 02/2024 - 02/2007
66	Therapeutics 10/2023 - 09/2002
12	Drug Therapy (Chemotherapy) 07/2022 - 05/2007
10	Radiotherapy 09/2023 - 05/2007
10	Nephrectomy 06/2023 - 04/2008
9	Prostatectomy (Retropubic Prostatectomy) 09/2023 - 12/2007
7	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 02/2003
7	Thrombectomy 10/2019 - 09/2014
7	Cystectomy 07/2018 - 09/2004
4	Neoadjuvant Therapy 07/2018 - 09/2004
3	Brachytherapy 09/2023 - 06/2007
3	Immunotherapy 07/2022 - 05/2007
2	Precision Medicine 01/2022 - 02/2009
2	Aftercare (After-Treatment) 11/2021 - 02/2010
2	Salvage Therapy 11/2020 - 08/2008
2	Length of Stay 01/2018 - 08/2015
2	Palliative Care (Palliative Therapy) 04/2011 - 10/2005
2	Adjuvant Chemotherapy 09/2009 - 10/2007